metricas
covid
Enfermedades Infecciosas y Microbiología Clínica (English Edition) Which corticosteroid should be used in severe pneumonia?
Journal Information
Vol. 43. Issue 2.
Pages 121 (February 2025)
Letter to the Editor
Full text access
Which corticosteroid should be used in severe pneumonia?
¿Qué corticosteroide debería emplearse en la neumonía grave?
Visits
265
Javier Velasco Montesa,
Corresponding author
, María Victoria Pardo Gutiérrezb, Carlos Hernando Martínb, Silvia González Díezc
a Departamento de Enfermedades Infecciosas, Hospital San Pedro, Logroño, La Rioja, Spain
b Servicio de Medicina Interna, Hospital Santos Reyes, Aranda de Duero, Burgos, Spain
c Médico de Atención Primaria, Servicio Riojano de Salud, Logroño, La Rioja, Spain
This item has received
Article information
Full Text
Bibliography
Download PDF
Statistics
Full Text
Dear Editor,

We have read with interest the article on optimising the diagnostic and therapeutic approach to pneumonia, published in a recent issue of your journal.1 Among the authors’ final recommendations was to use corticosteroids in patients with community-acquired pneumonia and septic shock, as well as in those who require admission to the ICU, provided that influenza has been ruled out as the cause. More specifically, they suggest the use of methylprednisolone at a dose of 0.5&#¿;mg/kg/12&#¿;h. The authors add that this adjuvant treatment should be started early (first 24&#¿;h) and maintained for no more than 5–7 days. We are surprised by the recommendation to use methylprednisolone instead of hydrocortisone. While methylprednisolone has not shown a benefit in terms of survival,2 hydrocortisone did show benefit in one of the clinical trials that the authors themselves include in their work.3

References
[1]
M. Fernández-Ruiz, J.J. Castón, J.L. del Pozo, J. Carratalà, J. Fortún, M. Salavert, et al.
How can we optimize the diagnostic and therapeutic approach to pneumonia? Expert opinion-based recommendations.
Enferm Infecc Microbiol Clin (Engl Ed), 42 (2024), pp. 442-452
[2]
G.U. Meduri, M.C. Shih, L. Bridges, T.J. Martin, A. El-Solh, N. Seam, et al.
Low-dose methylprednisolone treatment in critically ill patients with severe community acquired pneumonia.
Intensive Care Med, 48 (2022), pp. 1009-1023
[3]
P.F. Dequin, F. Meziani, J.P. Quenot, T. Kamel, J.D. Ricard, J. Badie, et al.
Hydrocortisone in severe community-acquired pneumonia.
N Engl J Med, 388 (2023), pp. 1931-1941
Copyright © 2024. Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica
Download PDF
Article options
Tools